[1] 毕新刚, 韩仁强, 周金意. 2009年中国前列腺癌发病和死亡分析[J]. 中国肿瘤, 2013, 22(6): 417-422.
[2] Singh AS, Figg WD. In vivo models of prostate cancer metastasis to bone[J]. J Urol, 2005, 174(3): 820-826.
[3] Wan X, Li ZG, Yingling JM, et al. Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth[J]. bone, 2012, 50(3): 695-703.
[4] Yang M, Jiang P, Sun FX. A fluorescent orthotopic bone metastasis model of human prostate cancer[J]. Cancer Research, 1999, 59(4): 781-786.
[5] Corey E, Quinn JE, Vessella RL. A novel method of generating prostate cancer metastases from orthotopic implants[J]. Prostate, 2003, 56(2): 110-114.
[6] 孙萍,王怡,孙志东,等.利用荧光素酶标记的肿瘤细胞建立肝原位移植模型及其活体成像[J]. 生物技术通讯, 2008, 19(3): 383-385.
[7] Tao K, Fang M, Alroy J, et al. Imagable 4T1 model for the study of late stage breast cancer[J]. BMC Cancer, 2008, 8:228.
[8] Wang H, Yu C, Gao X, et al. The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells[J]. Cancer Cell, 2015, 27(2): 193-210.
[9] 李天然, 田嘉禾. 小动物PET及PET-CT 及其在分子影像学中的应用[J]. 国际放射医学核医学杂志, 2008, 32(1): 1-4.
[10] Deroose CM, De A, Loening AM, et al. Multimodality imaging of tumor xenografts and metastases in mice with combined small animal PET, small-animal CT and bioluminescence imaging[J]. J Nucl Med, 2007, 48(2): 295-303.
[11]Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms[J]. Cell, 2011, 147(2): 275-292.
[12]Cox TR, Rumney RM, Schoof EM, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase[J]. Nature, 2015, 522(7554): 106-110.
[13]Fernandes RS, Dos Santos Ferreira D, de Aguiar Ferreira C, et al. Development of imaging probes for bone cancer in animal models. A systematic review[J]. Biomed Pharmacother, 2016, 83: 1253-1264. |